(Total Views: 53)
Posted On: 03/29/2021 1:19:55 PM
Post# of 107213

$CURR CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline https://finance.yahoo.com/news/cure-pharmaceu...00116.html

